Get the Stockscreener App
1.56
4.29%
-0.07
After Hours:
1.57
0.01
+0.64%
Pacific Biosciences Of California Inc Stock (PACB) Latest News
Uncertain Federal Research Funding Is The Latest Blow For Already-Battered PacBio (PACB) - Seeking Alpha
PacBio cut to Neutral at Goldman Sachs after guidance cut - MSN
Revenue Downgrade: Here's What Analysts Forecast For Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Simply Wall St
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 14% - Yahoo Finance
Analysts Issue Forecasts for PACB FY2025 Earnings - MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Michele Farmer Sells 24,349 Shares - MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
A chromosome-scale reference assembly of Vigna radiata enables delineation of centromeres and telomeres - Nature.com
How HiFi sequencing is making a difference for rare disease research at Children’s Mercy - Pacific Biosciences
Traders Purchase High Volume of Pacific Biosciences of California Call Options (NASDAQ:PACB) - MarketBeat
Pacific Biosciences Executives Conduct Major Stock Transactions - TradingView
Pacific Biosciences Officer Sells Over 259K Shares - TradingView
PacBio to Present at TD Cowen's 45th Annual Health Care Conference on March 4, 2025 - Nasdaq
The Goldman Sachs Group Cuts Pacific Biosciences of California (NASDAQ:PACB) Price Target to $1.50 - MarketBeat
PacBio to Participate in TD Cowen's 45th Annual Health Care Conference - Quantisnow
Life sciences stocks fall on NIH funding concerns - MSN
Where Pacific Biosciences Stands With Analysts - Benzinga
Pacific Biosciences of California (NASDAQ:PACB) Stock Rating Upgraded by StockNews.com - MarketBeat
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap DownTime to Sell? - MarketBeat
Pacific Biosciences of California (NASDAQ:PACB) Announces Quarterly Earnings Results - MarketBeat
StockWatch: NIH Indirect Cost Cuts Shake Tools Stocks - Genetic Engineering & Biotechnology News
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now - MSN
Sumitomo Mitsui Trust Group Inc. Decreases Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - MarketBeat
Stephens Reiterates Overweight Rating for Pacific Biosciences of California (NASDAQ:PACB) - MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Earnings Call Transcript - Insider Monkey
Pacific Biosciences of California Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Pacific Biosciences of California (PACB) to Release Quarterly Earnings on Thursday - MarketBeat
PacBio's Strategic Talent Move: 700K Share Package Signals Major Executive Addition - StockTitan
PacBio Grants Equity Incentive Award to New Employee - Quantisnow
PacBio Grants Equity Incentive Award to New Employee - GlobeNewswire Inc.
Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Ca - GuruFocus.com
Pacific Biosciences of California (NASDAQ:PACB) Releases Earnings Results, Meets Estimates - MarketBeat
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday - Benzinga
PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall - Yahoo Finance
UBS Adjusts Price Target on Pacific Biosciences of California to $1.50 From $2, Keeps Neutral Rating - Marketscreener.com
Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance
Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Call Highlights: Navigating ... By GuruFocus - Investing.com Canada
Pacific Biosciences: Q4 Earnings Snapshot - Huron Daily Tribune
PacBio outlines 2025 revenue guidance of $155M-$170M amid new product launches - MSN
Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates - MSN
Compared to Estimates, Pacific Biosciences (PACB) Q4 Earnings: A Look at Key Metrics - MSN
PacBio (NASDAQ:PACB) Misses Q4 Sales Targets - Yahoo Finance
Pacific Biosciences Of California, Inc. Q4 Earnings Summary - Nasdaq
PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results - TradingView
PacBio Reports Q4 2024 Financial Results Highlighting Revenue Decline and Strategic Developments - Nasdaq
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
PacBio Earnings: $154M Debt Restructuring Win Masks 33% Revenue Decline - StockTitan
Pacific Biosciences Of California Q4 24 Earnings Conference Call At 4:30 PM ET - Nasdaq
Trump’s Cuts to Medical Research Are Hurting These Stocks - Barron's
How HiFi sequencing lays the groundwork for accelerating rare disease diagnostics in the clinic - Pacific Biosciences
1.29%
2.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):